Ana C. Xavier

<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang et al. · Clinical Cancer Research · 2007 · 600 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo et al. · Annals of Oncology · 2007 · 270 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas

Ximing Tang, Marileila Varella‐Garcia, Ana C. Xavier et al. · Cancer Prevention Research · 2008 · 102 citations · Full text

Medicine, Oncology, Pathology +17

R‐<scp>CHOP </scp><i>versus</i> dose‐adjusted R‐<scp>EPOCH</scp> in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis

Nirav N. Shah, Anikó Szabó, Scott F. Huntington et al. · British Journal of Haematology · 2017 · 100 citations · Full text

Medicine, Oncology, Chemotherapy +14

Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases

Luciano J. Costa, Ana C. Xavier, Amy E. Wahlquist et al. · Blood · 2013 · 96 citations

Medicine, Hematology, Oncology +10